Reinhart, Ramona; Kaufmann, Thomas (2018). IL-4 enhances survival of in vitro-differentiated mouse basophils through transcription-independent signaling downstream of PI3K. Cell death & disease, 9(7), p. 713. Nature Publishing Group 10.1038/s41419-018-0754-z
|
Text
Kaufmann_IL-4 enhances survival of in .pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (2MB) | Preview |
Interleukin 4 (IL-4) is a critical cytokine implicated with T2 immune reactions, which are linked to pathologic conditions of allergic diseases. In that context, the initiation of T2 responses can critically depend on early basophil-derived IL-4 to activate T-cell responses, which then amplify IL-4 secretion. As a pleiotropic cytokine, IL-4 acts on a broad variety of hematopoietic and non-hematopoietic cells. However, the effect of IL-4 on basophils themselves, which are emerging as relevant players in allergic as well as autoimmune diseases, was only scarcely addressed so far. Here we used in vitro-differentiated mouse basophils to investigate the direct effects of IL-4 on cellular viability and surface expression of the high-affinity receptor for IgE, FcεRI. We observed that IL-4 elicits pronounced pro-survival signaling in basophils, delaying spontaneous apoptosis in vitro to a degree comparable to the known pro-survival effects of IL-3. Our data indicate that IL-4-mediated survival depends on PI3K/AKT signaling and-in contrast to IL-3-seems to be largely independent of transcriptional changes but effectuated by post-translational mechanisms affecting BCL-2 family members among others. Additionally, we found that IL-4 signaling has a stabilizing effect on the surface expression levels of the critical basophil activation receptor FcεRI. In summary, our findings indicate an important regulatory role of IL-4 on in vitro-differentiated mouse basophils enhancing their survival and stabilizing FcεRI receptor expression through PI3K-dependent signaling. A better understanding of the regulation of basophil survival will help to define promising targets and consequently treatment strategies in basophil-driven diseases.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology |
Graduate School: |
Graduate School for Cellular and Biomedical Sciences (GCB) |
UniBE Contributor: |
Reinhart, Ramona, Kaufmann, Thomas (B) |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2041-4889 |
Publisher: |
Nature Publishing Group |
Language: |
English |
Submitter: |
Jana Berger |
Date Deposited: |
10 Jul 2018 09:16 |
Last Modified: |
29 Mar 2023 23:36 |
Publisher DOI: |
10.1038/s41419-018-0754-z |
PubMed ID: |
29915306 |
BORIS DOI: |
10.7892/boris.118418 |
URI: |
https://boris.unibe.ch/id/eprint/118418 |